Published in PLoS One on October 15, 2013
Simulation of the microscopic process during initiation of stent thrombosis. Comput Biol Med (2014) 0.79
Computational simulation of platelet interactions in the initiation of stent thrombosis due to stent malapposition. Phys Biol (2016) 0.77
Biodegradable Cable-Tie Rapamycin-eluting Stents. Sci Rep (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Clinical end points in coronary stent trials: a case for standardized definitions. Circulation (2007) 10.31
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation (2006) 3.08
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation (2003) 2.72
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol (2008) 2.11
Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv (2012) 2.01
Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol (2010) 1.86
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol (2008) 1.84
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J (2005) 1.81
Late coronary stent thrombosis. Circulation (2007) 1.54
ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients. J Am Coll Cardiol (2008) 1.54
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation (2009) 1.49
Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry. Catheter Cardiovasc Interv (2011) 1.46
Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol (2009) 1.45
Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol (2002) 1.42
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol (2009) 1.22
Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation (2009) 1.21
Stent thrombosis: an issue revisited in a changing world. Circulation (2003) 1.08
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. J Thromb Haemost (2010) 1.01
Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study. Eur Heart J (2008) 0.92
The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction. Am Heart J (2010) 0.87
Acute infection-inflammation and coronary stent thrombosis: an observational study. Intern Emerg Med (2010) 0.84
Stent thrombosis: a poor man's disease? Isr Med Assoc J (2009) 0.84
Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis. Am J Cardiol (2011) 0.81
Life after coronary stent thrombosis. Med Sci Monit (2009) 0.77
Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents. Arch Cardiovasc Dis (2008) 0.76
Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA (2010) 4.45
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA (2004) 2.86
Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med (2011) 2.28
Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med (2007) 2.15
Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm (2009) 2.08
Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care (2008) 1.91
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis (2007) 1.87
Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation. Am J Cardiol (2012) 1.79
Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest (2015) 1.70
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med (2009) 1.62
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56
The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. J Clin Psychiatry (2010) 1.56
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg (2008) 1.55
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Europace (2009) 1.45
Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc (2009) 1.44
A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg (2002) 1.43
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract (2009) 1.42
Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm (2007) 1.42
Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med (2008) 1.41
Therapeutic hypothermia is associated with improved neurologic outcome and survival in cardiac arrest survivors of non-shockable rhythms. Resuscitation (2011) 1.41
Fortuitous therapeutic effect of Taser shock for a patient in atrial fibrillation. Ann Emerg Med (2008) 1.39
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients. Curr Med Res Opin (2014) 1.36
Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens (2008) 1.35
The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care (2005) 1.22
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin (2008) 1.18
Effect of cinnamon on glucose control and lipid parameters. Diabetes Care (2007) 1.17
Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr (2009) 1.16
The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med (2009) 1.15
Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis. Ann Pharmacother (2012) 1.11
Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract (2010) 1.11
Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis. Am J Health Syst Pharm (2012) 1.07
Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis. BMC Fam Pract (2012) 1.07
Staying healthy. A public mess. Time (2002) 1.06
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail (2006) 1.02
Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med (2013) 1.02
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Pharmacotherapy (2009) 1.01
Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother (2008) 1.00
Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation. PLoS One (2012) 0.99
Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents. J Clin Psychopharmacol (2013) 0.98
Moxifloxacin and torsade de pointes. Ann Pharmacother (2007) 0.98
Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc (2011) 0.98
The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc (2011) 0.98
Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr (2008) 0.97
Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation (2003) 0.97
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg (2007) 0.97
Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy (2012) 0.96
Electromagnetic Interference (EMI) and arrhythmic events in ICD patients undergoing gastrointestinal procedures. Pacing Clin Electrophysiol (2007) 0.95
Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging (2012) 0.95
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther (2008) 0.95
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94
Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother (2002) 0.94
Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis. Ann Pharmacother (2010) 0.94
Why we worry about the things we shouldn't...and ignore the things we should. Time (2006) 0.94
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation. Curr Med Res Opin (2014) 0.94
Atazanavir: a new protease inhibitor to treat HIV infection. Am J Health Syst Pharm (2004) 0.93
Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models. PLoS One (2013) 0.93
Chapter 8: meta-analysis of test performance when there is a "gold standard". J Gen Intern Med (2012) 0.93
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg (2009) 0.91
The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth (2008) 0.90
The Association Between Baseline Left Atrial Volume Index and All-Cause Mortality in Patients with Heart Failure: A Meta-Analysis. Conn Med (2015) 0.89
Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord (2008) 0.89
Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. Am J Health Syst Pharm (2009) 0.89
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol (2004) 0.88
Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm (2006) 0.88
The new drug crisis; addiction by prescription. Time (2010) 0.87
US prevalence of upper gastrointestinal symptoms: a systematic literature review. Am J Manag Care (2011) 0.87
Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. J Thorac Cardiovasc Surg (2010) 0.87
Evaluating the safety implications of aprotinin use: the Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS). J Thorac Cardiovasc Surg (2007) 0.87
The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis. J Am Coll Nutr (2009) 0.86
Effects of ischemia on repolarization in patients with single and multivessel coronary disease. Pacing Clin Electrophysiol (2003) 0.86
Contribution of intangible costs to the economic burden of multiple sclerosis. J Med Econ (2010) 0.86
The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study. Pacing Clin Electrophysiol (2013) 0.86
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism. J Med Econ (2013) 0.85
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm (2010) 0.85
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol (2007) 0.85
Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg (2004) 0.85
Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother (2004) 0.85
The impact of suppressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol (2006) 0.85